| ||||
| ||||
Bill again aids is listed under the budget of the NCI......I know you
enjoy states; so here they are my friend.
Appropriations of the NCI
1938-1994
1938 through 1968
$1,690,550,220
1969
185,149,500
1970
190,486,000
14.0%
1971
230,383,000
$4,410,425,220
1972
378,794,000
1973
492,205,000
1974
551,191,500
1975
691,666,000
1
1976
761,727,000
"TQ"
152,901,000
2
1977
815,000,000
1978
872,388,000
3
1979
937,129,000
1980
1,000,000,000
4
1981
989,355,000
5
1982
986,617,000
6
86.0%
1983
987,642,000
7
$27,142,476,000
1984
1,081,581,000
8
1985
1,183,806,000
1986
1,264,159,000
9
1987
1,402,837,000
10
1988
1,469,327,000
11
1989
1,593,536,000
12
1990
1,664,000,000
13
1991
1,766,324,000
14
1992
1,989,278,000
15
1993
2,007,483,000
16
1994
2,082,267,000
1995
2,135,119,000
17
Total (1938-1995)
$31,552,901,220
Transition Quarter ("TQ") --
July 1, 1976 through September 30, 1976. The interim period in changing
of the Federal Fiscal Year
from July 1 through June 30 to October 1 through September 30.
1 Includes $18,163,000 for training funds provided by Continuing
Resolution.
2 Includes $3,201,000 for training funds provided by Continuing
Resolution.
3 Includes $20,129,000 for training funds provided by Continuing
Resolution.
4 1980 appropriation authorized under a Continuing Resolution.
5 Reflects 1981 rescission of $11,975,000.
6 Amount included in continuing resolution. Includes $47,988,000
transferred to the National
Institute of Environmental Health Sciences for the National Toxicology
Program.
7 Appropriated under Continuing Resolution and Supplemental
Appropriation Bill.
8 Includes $23,861,000 for training funds provided by a Continuing
Resolution and
$4,278,000 in a Supplemental Appropriation Bill.
9 Includes $6,000,000 from a Supplemental Appropriation Bill.
10 Authorized under Omnibus Continuing Resolution.
11 Authorized under Omnibus Continuing Resolution.
12 Appropriation prior to reduction contained in G.P. 517 (-$19,122,000)
and G.P. 215
(-$2,535,000) and P.L. 100-436, Section 213, (-$1,013,000).
13 Appropriation prior to reduction contained in P.L. 101-166
(-$6,839,000) and P.L.
101-239 (-$22,829,000).
14 Appropriation prior to reductions in P.L. 101-517 (-$8,972,000 for
salary and expense
reduction; -$42,568,000 for across-the-board reduction).
15 Appropriation prior to reductions in P.L. 102-170 (-$21,475,000 for
salary and expense
reduction; -$1,262,000 for travel reduction; $15,000,000 transferred to
other institutes for
cancer research).
16 Appropriation prior to reductions in P.L. 102-294 (-$16,060,000 for
.8% reduction to all
line items, -$9,933,000 for S&E reduction, -$139,000 for consultant
services reduction.)
17 Appropriation prior to reductions in PL 103-211 (-$1,883,000 for
Procurement
Reduction;-$116,000 for SLUC Reduction;-$1,052,000 for Bonus Pay
Reduction). Includes
$218,199,000 of AIDS funding.
National Cancer Institute
Obligations and Outlays
Fiscal Year 1987-1994
(Dollars in Millions)
$ in Millions
1987
1988
1989
1990
1991
1992
1993
1994
Prior Year Outlays
$680
$723
$815
$885
$885
$831
$1,099
$1,108
Current Year Outlays
565
680
765
759
739
961
843
901
Total Outlays
1,245
1,403
1,580
1,644
1,624
1,792
1,942
2,009
Current Year Obligations
1,403
1,468
1,570
1,644
1,713
1,948
1,978
2,076
Obligations:
Orders placed, grants awarded, contract increments funded,
salaries earned and
similar financial transactions which legally utilize or
reserve an appropriation for
expenditure.
Outlays:
Payments (cash or checks) made from appropriations.
Fiscal Year
Number of Full Time Equivalents
Number of Employees
Cancer
AIDS
Total
1985
2,145
85
2,230
2,195
1986
2,003
98
2,101
2,096
1987
1,981
129
2,110
2,272
1988
2,137
146
2,283
2,302
1989
1,985
188
2,173
2,201
1990
1,960
232
2,192
2,322
1991
2,045
300
2,345
2,437
1992
2,219
306
2,525
2,604
1993
2,184
300
2,484
2,425
1994
2,081
301
2,382
2,307
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
|